Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
Donald P. Tashkin, Michael D. Roth, Philip J. Clements, et al.·2016·The Lancet Respiratory Medicine